Corcept Therapeutics Inc (CORT)
52.62
+0.79
(+1.52%)
USD |
NASDAQ |
Nov 18, 16:00
52.63
+0.01
(+0.02%)
After-Hours: 20:00
Corcept Therapeutics Price: 52.62 for Nov. 18, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 18, 2024 | 52.00 | 52.99 | 51.69 | 52.62 | 740925.0 |
| Nov 15, 2024 | 55.09 | 55.22 | 51.51 | 51.83 | 1.369M |
| Nov 14, 2024 | 56.40 | 57.50 | 54.49 | 54.79 | 836841.0 |
| Nov 13, 2024 | 58.02 | 59.26 | 56.41 | 56.45 | 581496.0 |
| Nov 12, 2024 | 59.00 | 59.98 | 57.00 | 57.79 | 1.166M |
| Nov 11, 2024 | 59.88 | 60.05 | 58.02 | 59.06 | 1.220M |
| Nov 08, 2024 | 54.30 | 61.66 | 54.30 | 59.60 | 1.728M |
| Nov 07, 2024 | 54.11 | 55.24 | 53.65 | 54.30 | 871048.0 |
| Nov 06, 2024 | 54.08 | 54.88 | 53.06 | 54.23 | 981796.0 |
| Nov 05, 2024 | 50.00 | 52.35 | 49.51 | 52.14 | 1.253M |
| Nov 04, 2024 | 47.63 | 51.32 | 47.63 | 50.06 | 1.498M |
| Nov 01, 2024 | 48.61 | 48.97 | 46.38 | 47.62 | 1.462M |
| Oct 31, 2024 | 45.99 | 49.92 | 42.01 | 48.97 | 2.710M |
| Oct 30, 2024 | 47.67 | 48.65 | 46.28 | 46.89 | 1.426M |
| Oct 29, 2024 | 48.04 | 48.73 | 47.62 | 48.21 | 821989.0 |
| Oct 28, 2024 | 47.51 | 49.19 | 47.44 | 48.34 | 682956.0 |
| Oct 25, 2024 | 47.68 | 48.40 | 47.25 | 47.28 | 933325.0 |
| Oct 24, 2024 | 47.97 | 49.04 | 47.02 | 47.24 | 852788.0 |
| Oct 23, 2024 | 48.57 | 49.36 | 47.51 | 48.06 | 793911.0 |
| Oct 22, 2024 | 49.00 | 49.54 | 48.78 | 48.92 | 960048.0 |
| Oct 21, 2024 | 49.92 | 50.00 | 48.61 | 49.11 | 1.550M |
| Oct 18, 2024 | 47.79 | 50.07 | 47.46 | 49.75 | 3.005M |
| Oct 17, 2024 | 47.66 | 48.46 | 46.72 | 47.17 | 864903.0 |
| Oct 16, 2024 | 46.90 | 47.42 | 46.05 | 47.27 | 776353.0 |
| Oct 15, 2024 | 45.18 | 46.98 | 45.17 | 46.84 | 831511.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
10.11
Minimum
Mar 16 2020
59.60
Maximum
Nov 08 2024
23.48
Average
22.92
Median
Price Benchmarks
| Catalyst Pharmaceuticals Inc | 20.82 |
| Madrigal Pharmaceuticals Inc | 303.49 |
| ADMA Biologics Inc | 19.54 |
| Alnylam Pharmaceuticals Inc | 232.27 |
| Akebia Therapeutics Inc | 1.80 |
Price Related Metrics
| PE Ratio | 41.76 |
| PS Ratio | 9.328 |
| PEG Ratio | 0.7517 |
| Price to Book Value | 8.630 |
| Price to Free Cash Flow | 41.11 |
| Earnings Yield | 2.39% |
| Market Cap | 5.513B |
| PEGY Ratio | 0.7517 |
| Operating PE Ratio | 40.90 |
| Normalized PE Ratio | 41.76 |